Revolutionizing Healthcare: Breakthroughs and Innovations in the Amniotic Membrane Market | Forecast 2023 – 2028 | Renub Research
Renub Research report titled “Amniotic Membrane Market, Global Forecast, by Product (Cryopreserved Amniotic Membranes & Lyophilization Amniotic Membrane), Application (Surgical Wounds, Ophthalmology & Others), End User (Hospital, Ambulatory Surgical Centers, Specialty Clinics, and Research & Academic Institutes), Region (North America, Europe, Asia-Pacific, Latin America, Middle East & Africa, Rest of World) Company Analysis 2022-2028,” finds that the Amniotic Membrane Market size is anticipated to attain US$ 5.30 Billion by 2030.
Amniotic membrane (AM) or amnion is a thin membrane on the inner side of the fetal placenta; it com- pletely surrounds the embryo and delimits the amniotic cavity, which is filled by amniotic liquid. In recent years, the structure and function of the amnion have been investigated, particularly the pluripotent properties of AM cells, which are an attractive source for tissue transplantation. AM has anti-inflammatory, anti-bacterial, anti-viral and immunological characteristics, as well as antiangiogenic and pro- apoptotic features. AM is a promoter of epithelialization and is a non-tumorigenic tissue and its use has no ethical problems. Because of its attractive properties, AM has been applied in several surgical procedures related to ocular surface reconstruction and the genitourinary tract, skin, head and neck, among others. So far, the best known and most auspicious applications of AM are ocular surface recon struction, skin applications and tissue engineering. However, AM can also be applied in oncology. In this area, AM can prevent the delivery of nutrients and oxygen to cancer cell and consequently interfere with tumour angiogenesis growth and metastasis.
Request a free sample copy of the report: https://www.renub.com/request-sample-page.php?gturl=amniotic-membrane-market-p.php
Amniotic membrane (AM) or amnion is a thin
membrane on the inner side of the fetal placenta; it com-
pletely surrounds the embryo and delimits the amniotic
cavity, which is filled by amniotic liquid. In recent years,
the structure and function of the amnion have been investi-
gated, particularly the pluripotent properties of AM cells,
which are an attractive source for tissue transplantation. AM
has anti-inflammatory, anti-bacterial, anti-viral and immu-
nological characteristics, as well as anti-angiogenic and pro-
apoptotic features. AM is a promoter of epithelialization and
is a non-tumorigenic tissue and its use has no ethical prob-
lems. Because of its attractive properties, AM has been
applied in several surgical procedures related to ocular sur-
face reconstruction and the genito-urinary tract, skin, head
and neck, among others. So far, the best known and mos
Amniotic membrane (AM) or amnion is a thin
membrane on the inner side of the fetal placenta; it com-
pletely surrounds the embryo and delimits the amniotic
cavity, which is filled by amniotic liquid. In recent years,
the structure and function of the amnion have been investi-
gated, particularly the pluripotent properties of AM cells,
which are an attractive source for tissue transplantation. AM
has anti-inflammatory, anti-bacterial, anti-viral and immu-
nological characteristics, as well as anti-angiogenic and pro-
apoptotic features. AM is a promoter of epithelialization and
is a non-tumorigenic tissue and its use has no ethical prob-
lems. Because of its attractive properties, AM has been
applied in several surgical procedures related to ocular sur-
face reconstruction and the genito-urinary tract, skin, head
and neck, among others. So far, the best known and mos
Amniotic membrane (AM) or amnion is a thin
membrane on the inner side of the fetal placenta; it com-
pletely surrounds the embryo and delimits the amniotic
cavity, which is filled by amniotic liquid. In recent years,
the structure and function of the amnion have been investi-
gated, particularly the pluripotent properties of AM cells,
which are an attractive source for tissue transplantation. AM
has anti-inflammatory, anti-bacterial, anti-viral and immu-
nological characteristics, as well as anti-angiogenic and pro-
apoptotic features. AM is a promoter of epithelialization and
is a non-tumorigenic tissue and its use has no ethical prob-
lems. Because of its attractive properties, AM has been
applied in several surgical procedures related to ocular sur-
face reconstruction and the genito-urinary tract, skin, head
and neck, among others. So far, the best known and mos
The main products of the amniotic membrane are the cryopreserved amniotic membrane and lyophilization amniotic membrane. Lyophilization amniotic membrane refers to the process of preserving something by freezing it very quickly and then subjecting it to a vacuum which removes ice. The various applications involved surgical wounds, ophthalmology, and others, which are used in hospitals, ambulatory surgical centers (ASCs), specialty clinics, and research and academic institutes.
Amniotic Membrane Market is anticipated to grow at a CAGR of 11.68% from 2022 to 2030
Amniotic membrane is expected to exhibit significant market growth during the forecast period, owing to growth in technological innovations to develop cost-effective therapies. Rise in amniotic membrane transplantation, rise in awareness and education about the benefits of amniotic membrane transplantation, and growth of geriatric population propel the market growth. However, the lack of healthcare professionals is expected to restrain the amniotic membrane market growth. Conversely, huge market potential in developing regions is expected to offer opportunities for market growth during the forecast period.
Amniotic membrane (AM) or amnion is a thin
membrane on the inner side of the fetal placenta; it com-
pletely surrounds the embryo and delimits the amniotic
cavity, which is filled by amniotic liquid. In recent years,
the structure and function of the amnion have been investi-
gated, particularly the pluripotent properties of AM cells,
which are an attractive source for tissue transplantation. AM
has anti-inflammatory, anti-bacterial, anti-viral and immu-
nological characteristics, as well as anti-angiogenic and pro-
apoptotic features. AM is a promoter of epithelialization and
is a non-tumorigenic tissue and its use has no ethical prob-
lems. Because of its attractive properties, AM has been
applied in several surgical procedures related to ocular sur-
face reconstruction and the genito-urinary tract, skin, head
and neck, among others. So far, the best known and mos
All the key players have been covered 3 Viewpoints
- Overview
- Recent Development
- Revenue
Company Analysis
- Stryker Corporation
- Smith & Nephew plc
- Integra LifeSciences Holdings
- MiMedx
- Organogenesis Net
- Wright Medical Group Inc
- Applied Biologics LLC
- FzioMedInc
- Katena, Inc
- Tissue-Tech Inc
Product – Market have been covered 2 Viewpoints
- Cryopreserved Amniotic Membranes
- Lyophilization Amniotic Membrane
Application – Market have been covered 3 Viewpoints
- Surgical Wounds
- Ophthalmology
- Others
End User – Market have been covered 4 Viewpoints
- Hospital
- Ambulatory Surgical Centers
- Specialty Clinics
- Research & Academic Institutes
Region – Market have been covered 6 Viewpoints
- North America
1.1 United States
1.2 Canada
- Europe
2.1 Germany
2.2 United Kingdom
2.3 France
2.4 Italy
2.5 Netherlands
2.6 Spain
- Asia Pacific
3.1 China
3.2 South Korea
3.3 Japan
3.4 India
3.5 Indonesia
3.6 Malaysia
3.7 Australia
- Latin America
4.1 Argentina
4.2 Brazil
4.3 Mexico
4.4 Colombia
- Middle East & Africa
5.1 Saudi Arabia
5.2 UAE
5.3 Israel
5.4 South Africa
- Rest of World
About the Company:
Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.
Contact Us:
Renub Research
Phone No: +1-478-202-3244 | +91-120-421-9822 (IND)
Email: info@renub.com
LinkedIn: https://in.linkedin.com/company/renub-research
Web: www.renub.com
